TrialPloS one2019

Systemic management of malignant meningiomas: A comparative survival and molecular marker analysis between Octreotide in combination with Everolimus and Sunitinib.

Andrés F Cardona et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.